Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drug use, spending varies widely in U.S. by region
Fierce Pharma
Friday, October 18, 2013 - 6:20pm
tags:
drug spending, Medicare
Pfizer: The Menopause Opportunity
Seeking Alpha
Friday, October 18, 2013 - 6:19pm
tags:
Pfizer, Duavee, menopause, Ligand Pharmaceuticals, Eli Lilly, Hisamitsu, hot flashes
Arena's Belviq Sales Flat - Equity Holds
Seeking Alpha
Friday, October 18, 2013 - 6:16pm
tags:
Belviq, obesity, Eisai, Arena Pharmaceuticals
FDA panel backs Paladin Labs' parasitic disease drug
Reuters
Friday, October 18, 2013 - 5:48pm
tags:
FDA, advisory panels, Paladin, leishmaniasis, Impavido
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Bloomberg
Friday, October 18, 2013 - 5:47pm
tags:
Actelion, FDA, Opsumit, PAH
Anacor reaches all-time high after saying it got $100M arbitration ruling in Valeant dispute
Yahoo/AP
Friday, October 18, 2013 - 12:02pm
tags:
Valeant Pharmaceuticals, Anacor, arbitration
Stem Cell Therapy: Coming Into Maturity And Becoming Medical Reality
Seeking Alpha
Friday, October 18, 2013 - 12:01pm
tags:
stem cells, AMR-001, vaccines, NeoStem
GE Healthcare boosts Q3 profits despite flat sales
Mass Device
Friday, October 18, 2013 - 11:06am
tags:
GE Healthcare, earnings, devices
EP Vantage: Eliquis projected sales off 60% for 2014
Fierce Pharma
Friday, October 18, 2013 - 11:04am
tags:
Eliquis, bloodthinners, Pfizer, Bristol-Myers Squibb
Pfizer Reports Results From Two Lyrica Capsules CV Phase 3b Studies
NASDAQ.com
Friday, October 18, 2013 - 11:03am
tags:
Pfizer, Lyrica, fibromyalgia, diabetic neuropathy
Switzerland Seizes One Million Fake Pfizer Pills in Zurich Airport
Bloomberg
Friday, October 18, 2013 - 11:00am
tags:
drug counterfeiting, Pfizer, Xanax, Switzerland
Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
Seeking Alpha
Friday, October 18, 2013 - 10:51am
tags:
Celldex, ImmunoCellular Therapeutics, Enanta, Merrimack Pharmaceuticals, Vanda
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Friday, October 18, 2013 - 10:07am
tags:
JNJ, Remicade, Simponi, Stelara, Invokana
AstraZeneca hit with lawsuit by former employee
West Virginia Record
Friday, October 18, 2013 - 9:54am
tags:
AstraZeneca, sexual harassment
Alimera, pSivida Eye Drug Rejected by FDA
TheStreet.com
Friday, October 18, 2013 - 9:52am
tags:
Alimera, pSivida, FDA, Iluvien, diabetic macular edema
Atchoo! Who’s making money out of flu season
CNBC
Friday, October 18, 2013 - 9:34am
tags:
Flu, Novartis, GSK, Merck, Sanofi, AstraZeneca
Bubble-icious Biotech
Forbes
Friday, October 18, 2013 - 9:33am
tags:
IPOs, biotech
Ariad Forced to Shutter Vital Study of Iclusig Due to Toxicity
TheStreet.com
Friday, October 18, 2013 - 9:32am
tags:
Iclusig, Ariad Pharmaceuticals
Amgen's 3Q report to focus on cancer drugmaker purchase, testing of its own experimental drugs
Yahoo/AP
Friday, October 18, 2013 - 9:31am
tags:
Amgen, earnings
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thursday, October 17, 2013 - 6:18pm
tags:
Cleveland Clinic, JNJ, Pharmacyclics, Novartis, serelaxin, ibrutinib, sofosbuvir, Gilead

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.